Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Children | 1 |
| Drug Therapy | 1 |
| Drug Use | 1 |
| Federal Government | 1 |
| Federal Regulation | 1 |
| Government Role | 1 |
| Industry | 1 |
| Mental Disorders | 1 |
| Pediatrics | 1 |
| Pharmacology | 1 |
| More ▼ | |
Source
| Journal of the American… | 1 |
Author
| Andreason, Paul J. | 1 |
| Deveaugh-Geiss, Joseph | 1 |
| Emslie, Graham | 1 |
| Ford, Lisa M. | 1 |
| Greenhill, Laurence | 1 |
| Mangum, Barry | 1 |
| March, John | 1 |
| Murphy, Dianne | 1 |
| Prentice, Ernest | 1 |
| Roberts, Rosemary | 1 |
| Shapiro, Mark | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkDeveaugh-Geiss, Joseph; March, John; Shapiro, Mark; Andreason, Paul J.; Emslie, Graham; Ford, Lisa M.; Greenhill, Laurence; Murphy, Dianne; Prentice, Ernest; Roberts, Rosemary; Silva, Susan; Swanson, James M.; van Zwieten-Boot, Barbara; Vitiello, Benedetto; Wagner, Karen Dineen; Mangum, Barry – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To give academic researchers, government officials, and industry scientists an opportunity to assess the state of pediatric psychopharmacology and identify challenges facing professionals in the field. Method: Increased federal spending and the introduction of pediatric exclusivity led to large increases in pediatric psychopharmacology…
Descriptors: Safety, Psychiatry, Mental Disorders, Research Needs
